de Martimprey, H., Bertrand, J., Fusco, A., Santoro, M., Couvreur, P., Vauthier, C., & Malvy, C. (2008). siRNA nanoformulation against the Ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma. Oxford University Press.
Čikaški stil citiranjade Martimprey, Henri, Jean-Remi Bertrand, Alfredo Fusco, Massimo Santoro, Patrick Couvreur, Christine Vauthier, i Claude Malvy. SiRNA Nanoformulation against the Ret/PTC1 Junction Oncogene Is Efficient in an in Vivo Model of Papillary Thyroid Carcinoma. Oxford University Press, 2008.
MLA način citiranjade Martimprey, Henri, et al. SiRNA Nanoformulation against the Ret/PTC1 Junction Oncogene Is Efficient in an in Vivo Model of Papillary Thyroid Carcinoma. Oxford University Press, 2008.